Results 1 to 10 of about 2,489,205 (210)

Autoimmune hemolytic anemia complicating a chronic neutrophilic leukemia: A case report of a rare association [PDF]

open access: yesClinical Case Reports, 2023
Key Clinical Message Chronic neutrophilic leukemia is a rare disease with a poor prognosis. Its diagnosis is challenging in the lack of genetic tools. It can infrequently be associated with autoimmune hemolytic anemia.
Rim Rakez   +5 more
doaj   +3 more sources

Case report: Leukemia cutis as the first manifestation of chronic neutrophilic leukemia in a 6-year-old girl [PDF]

open access: yesFrontiers in Pediatrics, 2022
Chronic neutrophilic leukemia (CNL) is a rare BCR-ABL negative myeloproliferative neoplasm that usually affects older adults with a poor prognosis. Leukemia cutis is an extramedullary manifestation of leukemia and may be misdiagnosed by dermatologists ...
Ya Bin Zhou   +3 more
doaj   +3 more sources

Transcriptomic signature can distinguish chronic neutrophilic leukemia from ambiguous neutrophilic leukemias [PDF]

open access: yesFrontiers in Genetics
BackgroundIdentifying uncommon neutrophilic leukemias presents a challenging task, owing to the analogous morphological characteristics and the dearth of molecular markers.
Chao Guo, Zhen-Ling Li
doaj   +3 more sources

Anti-inflammatory effects of ruxolitinib on chronic neutrophilic leukemia harboring CSF3R-T618I mutation with bilateral renal abscesses [PDF]

open access: yesLeukemia Research Reports, 2022
Chronic neutrophilic leukemia (CNL) is a rare myeloproliferative neoplasm (MPN) characterized by sustained mature neutrophilic leukocytosis. Recently, presence of colony-stimulating factor 3 receptor (CSF3R) mutations has been added to the diagnostic ...
Naohi Sahara   +10 more
doaj   +3 more sources

Successful Allogeneic Stem Cell Transplantation with Ruxolitinib Maintenance Therapy for CSF3R T618I Mutant Chronic Neutrophilic Leukemia [PDF]

open access: yesTurkish Journal of Hematology, 2023
, Chronic neutrophilic leukemia (CNL) is a rare potentially aggressive myeloproliferative neoplasm with oncogenic driver mutations in the colony-stimulating factor 3 receptor (CSF3R) found in approximately 83% of cases [1].
Peipei Ye   +4 more
doaj   +3 more sources

CSF3R Gln776X and ASXL1 mutations in multiple myeloma associated with chronic neutrophilic leukemia: case report and literature review [PDF]

open access: yesArchives of Medical Science
Multiple myeloma (MM) is a malignant clonal disorder of plasma cells, for which no cure has been found. Chronic neutrophilic leukemia (CNL) is a rare myeloproliferative tumor first described in 1920 [1].
Ying Han, Yajun Shi, Tao Wu, Jinmao Zhou
doaj   +3 more sources

Rare evolution of CSF3R-mutated chronic neutrophilic leukemia to t(4;12)(q12;p13) acute myeloid leukemia with SETBP1 mutation [PDF]

open access: yesLeukemia Research Reports, 2022
Chronic neutrophilic leukemia (CNL) is a rare myeloproliferative disease accompanied by mutations in CSF3R. Here, we present a patient with CNL who developed to acute myeloid leukemia (AML) at the same time that a t(4;12)(q12;p13) translocation appeared.
Maki Hirao   +8 more
doaj   +3 more sources

A novel colony stimulating factor 3 receptor activating mutation identified in a patient with chronic neutrophilic leukemia [PDF]

open access: yesHaematologica, 2022
Not available.
Breanna N. Maniaci   +4 more
doaj   +3 more sources

Chronic Neutrophilic Leukemia: A Comprehensive Review of Clinical Characteristics, Genetic Landscape and Management [PDF]

open access: yesFrontiers in Oncology, 2022
Chronic neutrophilic leukemia (CNL) represents a rare disease, that has been classified among the BCR/ABL-negative myeloproliferative neoplasms. The disease is characterized by marked leukocytosis with absolute neutrophilia and its clinical presentation ...
Thomas P. Thomopoulos   +4 more
doaj   +3 more sources

When monoclonal gammopathy‐associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakes [PDF]

open access: yeseJHaem, 2023
1Département d’Hématologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France 2InsermU1287, Gustave Roussy, Université Paris-Saclay, Villejuif, France 3Département d’Innovation Thérapeutique et d’Essais Précoces, Gustave Roussy, Université Paris-
Christophe Willekens   +19 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy